Kavalakatt Sina, Khadir Abdelkrim, Madhu Dhanya, Hammad Maha, Devarajan Sriraman, Abubaker Jehad, Al-Mulla Fahd, Tuomilehto Jaakko, Tiss Ali
Research Division, Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Research Division, Dasman Diabetes Institute, Kuwait City, Kuwait.
Front Endocrinol (Lausanne). 2019 Nov 6;10:762. doi: 10.3389/fendo.2019.00762. eCollection 2019.
Urocortin3 (UCN3) regulates metabolic functions and is involved in cellular stress response. Although UCN3 is expressed in human adipose tissue, the association of UCN3 with obesity and diabetes remains unclear. This study investigated the effects of Type 2 diabetes (T2D) and increased body weight on the circulatory and subcutaneous adipose tissue (SAT) levels of UCN3 and assessed UCN3 modulation by a regular physical exercise. Normal-weight ( = 37) and overweight adults with and without T2D ( = 98 and = 107, respectively) were enrolled in the study. A subset of the overweight subjects ( = 39 for each group) underwent a supervised 3-month exercise program combining both moderate intensity aerobic exercise and resistance training with treadmill. UCN3 levels in SAT were measured by immunofluorescence and RT-PCR. Circulatory UCN3 in plasma was assessed by ELISA and was correlated with various clinical and metabolic markers. Our data revealed that plasma UCN3 levels decreased in overweight subjects without T2D compared with normal-weight controls [median; 11.99 (0.78-86.07) and 6.27 (0.64-77.04), respectively; < 0.001], whereas plasma UCN3 levels increased with concomitant T2D [median; 9.03 (0.77-104.92) < 0.001]. UCN3 plasma levels were independently associated with glycemic index; fasting plasma glucose and hemoglobin A1c ( = 0.16 and = 0.20, < 0.05, respectively) and were significantly different between both overweight, with and without T2D, and normal-weight individuals (OR = 2.11 [1.84-4.11, 95% CI] and OR = 2.12 [1.59-3.10, 95% CI], < 0.01, respectively). Conversely, the UCN3 patterns observed in SAT were opposite to those in circulation; UCN3 levels were significantly increased with body weight and decreased with T2D. After a 3-month supervised exercise protocol, UCN3 expression showed a significant reduction in SAT of both overweight groups (2.3 and 1.6-fold change; < 0.01, respectively). In conclusion, UCN levels are differentially dysregulated in obesity in a tissue-dependent manner and can be mitigated by regular moderate physical exercise.
尿皮质素3(UCN3)调节代谢功能并参与细胞应激反应。尽管UCN3在人体脂肪组织中表达,但其与肥胖症和糖尿病之间的关联仍不明确。本研究调查了2型糖尿病(T2D)和体重增加对循环系统及皮下脂肪组织(SAT)中UCN3水平的影响,并评估了规律体育锻炼对UCN3的调节作用。研究纳入了体重正常(n = 37)以及患有和未患T2D的超重成年人(分别为n = 98和n = 107)。一部分超重受试者(每组n = 39)接受了为期3个月的有监督的运动计划,该计划结合了中等强度有氧运动和跑步机阻力训练。通过免疫荧光和逆转录聚合酶链反应(RT-PCR)测量SAT中的UCN3水平。采用酶联免疫吸附测定(ELISA)评估血浆中的循环UCN3,并将其与各种临床和代谢指标进行关联分析。我们的数据显示,与体重正常的对照组相比,未患T2D的超重受试者血浆UCN3水平降低[中位数分别为11.99(0.78 - 86.07)和6.27(0.64 - 77.04);P < 0.001],而伴随T2D时血浆UCN3水平升高[中位数为9.03(0.77 - 104.92);P < 0.001]。UCN3血浆水平与血糖指数独立相关;空腹血糖和糖化血红蛋白(分别为β = 0.16和β = 0.20,P < 0.05),并且在患有和未患T2D的超重个体与体重正常个体之间存在显著差异(分别为OR = 2.11 [1.84 - 4.11, 95% CI]和OR = 2.12 [1.59 - 3.10, 95% CI],P < 0.01)。相反,在SAT中观察到的UCN3模式与循环中的相反;UCN3水平随体重显著升高,随T2D降低。经过为期3个月的有监督运动方案后,两个超重组的SAT中UCN3表达均显著降低(变化倍数分别为2.3和1.6;P < 0.01)。总之,UCN水平在肥胖症中以组织依赖的方式存在差异失调,并且可以通过规律的适度体育锻炼得到缓解。